Ranibizumab for Diabetic Macular Edema

To evaluate the efficacy and safety of intravitreal ranibizumab in diabetic macular edema (DME) patients.Two parallel, methodologically identical, phase III, multicenter, double-masked, sham injection-controlled, randomized studies.Adults with vision loss from DME (best-corrected visual acuity [BCVA], 20/40-20/320 Snellen equivalent) and central subfield thickness ≥275 μm on time-domain optical coherence tomography (OCT).Monthly intravitreal...